SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir is currently under intense selling pressure as investors weigh market sentiment triggered by Michael Burrys high-profile, albeit deleted, social media critique comparing the company to Anthropic. While the community remains deeply divided, with some investors aggressively buying the dip on the belief that Palantirs proprietary data ontology remains an irreplaceable enterprise moat, others are pointing to bearish technicals and broader concerns regarding valuation in the software sector.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is seeing a surge in sentiment driven by its participation in Elon Musk's Terafab project and a newly expanded multiyear partnership with Google for AI infrastructure. The community is actively debating whether this momentum marks a sustainable turnaround for the foundry business or if the rapid price appreciation has pushed the stock into overextended territory.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius Group is trending as investors digest news of potential acquisition talks with AI21 Labs, a move viewed as a strategic capstone to transform the firm from a GPU renter into a full-stack AI Neocloud leader. The community is heavily focused on the stock's remarkable resilience and momentum relative to the broader sector, with many traders discussing its potential for further breakout alongside ongoing massive deal flow and hyperscaler partnerships.

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including sellers, advertising, and subscription services through internationally focused online stores. The AWS segment is composed of global sales of computers, storage, databases, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

Amazon is experiencing significant positive momentum fueled by a major expansion of its data center footprint in Mississippi and strong analyst sentiment regarding its AI chip business, which is reportedly generating massive revenue growth. Investors are also closely monitoring the company's deepening integration of AI across its e-commerce and logistics networks, while active discussions center on the long-term potential of the AWS AI ecosystem to drive outsized valuation gains.

Aimei Health Technology Co., Ltd. is a blank check company, which engages in entering a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses. The company was founded on April 27, 2023 and is headquartered in New York, NY.

Aimei Health Technology Co Ltd

Aimei Health Technology ($AFJK) is currently experiencing extreme volatility driven by its status as a low-float, catalyst-free momentum play that frequently triggers massive, rapid swings. The community remains deeply divided, with bulls actively coordinating volume to fuel potential short squeezes while bears label the stock a recurring pump-and-dump scheme prone to aggressive retracements.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

Sandisk is seeing explosive, momentum-driven buying as investors chase aggressive price target hikes and bullish analyst sentiment surrounding AI-fueled NAND memory demand. While some in the community celebrate the parabolic gains and speculate on a potential stock split, others are actively debating whether this vertical move is a sustainable cycle or an overheated bubble prone to a sharp reversal.

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip Astley-Sparke, Colin A. Love, and Robert Coffin in March 2015 and is headquartered in Woburn, MA.

Replimune Group Inc

Replimune Group is trading in focus as the company attempts to address FDA concerns from a prior complete response letter regarding its lead candidate RP1, with investors debating whether the resubmission successfully resolves regulatory hurdles. Community discussion is polarized between optimism over the drug's potential efficacy and clinical need, and skepticism regarding the adequacy of the trial design without a randomized control arm.

ServiceNow, Inc. engages in the provision of an end-to-end workflow automation platform for digital businesses. Its Now Platform is a cloud-based solution embedded with artificial intelligence (AI) and machine learning (ML). The company was founded by Frederic B. Luddy in June 2004 and is headquartered in Santa Clara, CA.

ServiceNow Inc

ServiceNow ($NOW) is currently trending as investors grapple with intense bearish sentiment and a sharp sell-off across the software sector, fueled by ongoing anxieties that AI advancements from competitors like Anthropic could disrupt established SaaS business models. While the stock has hit fresh lows and faces significant technical pressure, a vocal segment of the community is actively debating whether this represents a generational buying opportunity based on strong fundamentals and enterprise stickiness or a "falling knife" scenario driven by systemic shifts in how software is valued.

Marvell Technology, Inc. engages in the design, development, and sale of integrated circuits. Its products include data processing units, security solutions, automotive, coherent DSP, DCI optical modules, ethernet controllers, ethernet PHYs, ethernet switches, linear driver, PAM DSP, transimpedance amplifiers, fibre channel, HDD, SSD controller, storage accelerators, ASIC, and Marvell government solutions. It operates through the following geographical segments: United States, Singapore, Israel, India, China, and Others. The company was founded by Wei Li Dai and Pantas Sutardja in 1995 and is headquartered in Wilmington, DE.

Marvell Technology Inc

Marvell Technology is drawing significant investor interest after securing a $2 billion strategic investment and partnership with NVIDIA to integrate custom AI silicon and photonic solutions into the NVIDIA ecosystem. While the community remains divided over the impact of broader geopolitical tensions and market volatility on chip stocks, many are actively monitoring the stock's ability to maintain its technical momentum and break through key psychological resistance levels.

Innodata, Inc. is a data engineering company, which engages in providing artificial intelligence software platforms and management of its services. It operates through the following business segments: Digital Data Solutions (DDS), Synodex, and Agility. The DDS segment combines deep neural networks and human expertise in multiple domains to make unstructured information useable. The Synodex segment enables clients in the insurance and healthcare sectors to transform medical records into useable digital data and to apply technologies to the digital data to augment decision support. The Agility segment provides tools and related professional services that enable public relations and communications professionals to discover influencers, amplify messages, monitor coverage, and measure the impact of campaigns. The company was founded by Todd H. Solomon in 1988 and is headquartered in Ridgefield Park, NJ.

Innodata Inc

Innodata is currently trending as investors weigh potential M&A prospects and the company's strategic role in military defense and AI data training against broader market volatility and client concentration risks. Community sentiment is divided, with many long-term shareholders bullish on the company's expanding workforce and defense contracts while traders debate whether the stock is in a bearish accumulation phase or a deeper downtrend.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Hennion & Walsh Asset Management Inc. Purchases 161,910 Shares of Arcturus Therapeutics Holdings Inc. $ARCT

Hennion & Walsh Asset Management Inc. grew its position in Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT - Free Report) by 206.5% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 240,303 shares of the biotechnology company's stock after buying an additional 16...

Arcturus Therapeutics (NASDAQ:ARCT) Share Price Passes Below 200 Day Moving Average   - Should You Sell?

Arcturus Therapeutics (NASDAQ:ARCT) Stock Passes Below Two Hundred Day Moving Average - Here's What Happened...

Arcturus Therapeutics Refocuses on Rare Disease mRNA Pipeline After COVID Vaccine Success at ROTH Conf

Arcturus Therapeutics (NASDAQ:ARCT) CEO Joe Payne told investors at the 38th Annual ROTH Conference that the company is refocusing on rare disease programs after gaining approvals for its COVID-19 vaccine in more than 30 countries. Payne said Arcturus had initiated a rare disease strategy for messen...

Arcturus Therapeutics (NASDAQ:ARCT) Stock Rating Upgraded by B. Riley Financial

B. Riley Financial upgraded Arcturus Therapeutics to a "strong-buy" rating in a research report on Tuesday...

Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Receives Average Recommendation of "Moderate Buy" from Analysts

Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT - Get Free Report) has been given a consensus recommendation of "Moderate Buy" by the thirteen brokerages that are currently covering the stock...

Arcturus Therapeutics (NASDAQ:ARCT) Coverage Initiated at B. Riley Financial

B. Riley Financial started coverage on Arcturus Therapeutics in a research report on Wednesday. They issued a "buy" rating and a $22.00 target price for the company...

Arcturus Therapeutics Teases 12-Week Phase 2 CF Study After Well-Tolerated Inhaled mRNA Dosing

Arcturus Therapeutics (NASDAQ:ARCT) Chief Executive Officer Joe Payne told investors at the Leerink Partners Global Healthcare Conference that the company has advanced its inhaled messenger RNA...

Q1 EPS Forecast for Arcturus Therapeutics Reduced by Analyst

Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT - Free Report) - Equities researchers at HC Wainwright reduced their Q1 2026 EPS estimates for shares of Arcturus Therapeutics in a research note...

Citigroup Issues Pessimistic Forecast for Arcturus Therapeutics (NASDAQ:ARCT) Stock Price

Citigroup reduced their price objective on shares of Arcturus Therapeutics from $66.00 to $21.00 and set a "buy" rating on the stock in a research report on Thursday...

Arcturus Therapeutics to Attend Upcoming Investor Conference

Arcturus Therapeutics Holdings Inc. (the Company, Arcturus, Nasdaq: ARCT), a messenger RNA medicines company focused on the development of liver and respiratory rare disease therapeutics, today...

Arcturus Therapeutics Holdings, Inc. operates as a late-stage clinical mRNA medicines and vaccine company, which engages in the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases. Its products include LUNAR-COV19, LUNAR-FLU, LUNAR-OTC, and LUNAR-CF. The company was founded in 2013 and is headquartered in San Diego, CA.

Fiscal Period	Estimated	Reported	Surprise	Result
Q1 '26	-$1.01	--	--	N/A
Q4 '25	-$0.78	-$1.03	-32.58%	MISSED
Q3 '25	-$0.90	-$0.49	45.49%	BEAT
Q2 '25	-$0.89	-$0.34	61.87%	BEAT
Q1 '25	-$1.18	-$0.52	55.85%	BEAT

ARCT
Arcturus Therapeutics Holdings Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q1 '26

Historical Earnings

Latest ARCT News

ARCTArcturus Therapeutics Holdings Inc